Access

Business

Nature 435, 1159 (30 June 2005) | doi:10.1038/4351159b; Published online 29 June 2005

In brief

The New York-based, non-profit International AIDS Vaccine Initiative (IAVI) is to partner pharmaceutical giant GlaxoSmithKline in an effort to develop an AIDS vaccine.The partners say they will pursue a vaccine based on an adenovirus, which is stripped of its infectious genes, focusing on those that naturally infect chimpanzees.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

How Gsα activates adenylyl cyclase

Nature Structural Biology News and Views (01 Feb 1998)